Achieve Life Sciences Inc’s recent filing unveils that its Chief Financial Officer Oki Mark K unloaded Company’s shares for reported $0.15 million on Sep 18 ’25. In the deal valued at $2.92 per share,50,060 shares were sold. As a result of this transaction, Oki Mark K now holds 127,940 shares worth roughly $0.61 million.
Then, Stewart Richard Alistair sold 129,501 shares, generating $378,143 in total proceeds. Upon selling the shares at $2.92, the Chief Executive Officer now owns 228,875 shares.
Before that, Wan Jerry sold 14,070 shares. Achieve Life Sciences Inc shares valued at $38,974 were divested by the Principal Accounting Officer at a price of $2.77 per share. As a result of the transaction, Wan Jerry now holds 32,694 shares, worth roughly $0.16 million.
H.C. Wainwright initiated its Achieve Life Sciences Inc [ACHV] rating to a Buy in a research note published on August 21, 2025; the price target was $12. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in mid November with a ‘”a Buy”‘ rating. Raymond James began covering ACHV with “Strong buy” recommendation on September 27, 2024. Maxim Group maintained its rating on May 10, 2023. It rated ACHV as “a Buy”.
Price Performance Review of ACHV
On Tuesday, Achieve Life Sciences Inc [NASDAQ:ACHV] saw its stock jump 7.19% to $4.77. Over the last five days, the stock has lost -0.83%. Achieve Life Sciences Inc shares have fallen nearly -4.60% since the year began. Nevertheless, the stocks have risen 35.51% over the past one year. While a 52-week high of $5.78 was reached on 10/21/25, a 52-week low of $1.84 was recorded on 04/09/25.
Levels Of Support And Resistance For ACHV Stock
The 24-hour chart illustrates a support level at 4.43, which if violated will result in even more drops to 4.08. On the upside, there is a resistance level at 4.95. A further resistance level may holdings at 5.13.
How much short interest is there in Achieve Life Sciences Inc?
A steep rise in short interest was recorded in Achieve Life Sciences Inc stocks on 2025-10-31, growing by 1.7 million shares to a total of 6.1 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 4.39 million shares. There was a rise of 27.94%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 23, 2021 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $23 price target.
